A Study of LY2584702 in Participants With Advanced Cancer

Clinical trial NCT01394003 · TERMINATED

Trial details

NCT number: NCT01394003
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-11-01
Primary completion: 2011-04-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.